What is the ROCE (Return on Capital Employed) of ST Pharm Co this year?
The ROCE of ST Pharm Co is 0.09 undefined this year.
ST Pharm Co ROCE 2025
ST Pharm Co ROCE
0.09
Ticker
237690.KQ
ISIN
KR7237690003
In 2025, ST Pharm Co's return on capital employed (ROCE) was 0.09, a 64.82% increase from the 0.05 ROCE in the previous year.
ST Pharm Co Aktienanalyse
What does ST Pharm Co do?
ST Pharm Co Ltd is a Korean company specializing in the production of pharmaceutical products and dietary supplements. The company was founded in 2000 and has since gained a significant position in the Korean health market. The history of ST Pharm Co Ltd is closely linked to the growing importance of health and wellness in Korean society. The company recognized the trend very early on and was able to grow quickly by offering high-quality products that promote the well-being and health of customers. The company aims to improve the quality of life for its customers and help them achieve their health and wellness goals. ST Pharm Co Ltd is divided into various divisions to serve its customers optimally. The medical division focuses on prescription and over-the-counter drugs for the treatment of diseases such as diabetes, asthma, herpes, allergies, and many others. The company employs a variety of experts to ensure the quality and effectiveness of its medical products. In the dietary supplement division, ST Pharm Co Ltd offers a variety of products that aim to promote the health and well-being of customers. These include vitamins, minerals, omega-3 fatty acids, probiotics, weight loss supplements, and many others. The products are offered in a variety of forms such as capsules, tablets, powders, and liquids to meet the needs of customers. The company also offers a cosmetics division that focuses on skincare products to promote healthy and youthful skin. ST Pharm Co Ltd has developed special formulas enriched with natural ingredients to create effective and safe skincare products. The product range includes facial cleansers, moisturizers, anti-aging products, masks, and more. The business model of ST Pharm Co Ltd is based on a comprehensive research and development program that the company conducts to develop innovative products that meet the needs of customers. The company has invested significant resources in research and development to improve the quality and effectiveness of its products. It has close relationships with the academic world and other companies around the world, allowing it to access the latest technologies and developments. ST Pharm Co Ltd is also committed to developing and introducing environmentally friendly products that minimize environmental impact and allow for sustainable operation. The company has a comprehensive sustainability agenda and constantly works to improve its products and processes to reduce its environmental footprint. In summary, ST Pharm Co Ltd is a leading company in the Korean health and wellness industry. The company follows an innovative business model based on careful research and development to develop products of the highest quality and effectiveness. With a wide range of products including medical products, dietary supplements, and cosmetics, the company aims to support its customers in achieving their health and wellness goals. ST Pharm Co Ltd is also a company that prioritizes sustainability and promotes environmentally friendly products and processes. ST Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling ST Pharm Co's Return on Capital Employed (ROCE)
ST Pharm Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing ST Pharm Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
ST Pharm Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in ST Pharm Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about ST Pharm Co stock
How has the ROCE (Return on Capital Employed) of ST Pharm Co developed compared to the previous year?
The ROCE of ST Pharm Co has increased by 64.82% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of ST Pharm Co?
A high Return on Capital Employed (ROCE) indicates that ST Pharm Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of ST Pharm Co?
A low ROCE (Return on Capital Employed) can indicate that ST Pharm Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from ST Pharm Co impact the company?
An increase in the ROCE of ST Pharm Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of ST Pharm Co affect the company?
A decrease in ROCE of ST Pharm Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of ST Pharm Co?
Some factors that can affect ST Pharm Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of ST Pharm Co so important for investors?
The ROCE of ST Pharm Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can ST Pharm Co take to improve the ROCE?
To improve the ROCE, ST Pharm Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does ST Pharm Co pay?
Over the past 12 months, ST Pharm Co paid a dividend of 500 KRW . This corresponds to a dividend yield of about 0.65 %. For the coming 12 months, ST Pharm Co is expected to pay a dividend of 486.4 KRW.
What is the dividend yield of ST Pharm Co?
The current dividend yield of ST Pharm Co is 0.65 %.
When does ST Pharm Co pay dividends?
ST Pharm Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.
How secure is the dividend of ST Pharm Co?
ST Pharm Co paid dividends every year for the past 7 years.
What is the dividend of ST Pharm Co?
For the upcoming 12 months, dividends amounting to 486.4 KRW are expected. This corresponds to a dividend yield of 0.64 %.
In which sector is ST Pharm Co located?
ST Pharm Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von ST Pharm Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ST Pharm Co from 5/1/2024 amounting to 500 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.
When did ST Pharm Co pay the last dividend?
The last dividend was paid out on 5/1/2024.
What was the dividend of ST Pharm Co in the year 2024?
In the year 2024, ST Pharm Co distributed 500 KRW as dividends.
In which currency does ST Pharm Co pay out the dividend?
The dividends of ST Pharm Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von ST Pharm Co
Our stock analysis for ST Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ST Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.